SCHEMBL16628787

SCHEMBL16628787

CN1CCCC/C=C/C2CC2(C(=O)O)NC(=O)C2CC(OC(=O)c3ccc([N+](=O)[O-])cc3)CN2C1=O

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ MAPT P10636 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ ADRB3 P13945 1/20 0.35
▸ ADRA2B P18089 1/20 0.35
▸ ADRA2C P18825 1/20 0.35
▸ PTPN2 P17706 1/20 0.35
▸ PTPN1 P18031 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ CHRM2 P08172 1/20 0.33
▸ CHRM4 P08173 1/20 0.33
▸ CHRM1 P11229 1/20 0.33
▸ CHRM3 P20309 1/20 0.33
▸ CTSB P07858 1/20 0.32
▸ ACHE P22303 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16628788 1.00 POLB (0.40) POLBSMN1; SMN2MAPTALDH1A1ADRB3
SCHEMBL2843887 0.91 POLB (0.37) POLBSMN1; SMN2MAPTALDH1A1ADRB3
SCHEMBL8238400 0.91 POLB (0.37) POLBSMN1; SMN2MAPTALDH1A1ADRB3
SCHEMBL2843889 0.91 POLB (0.37) POLBSMN1; SMN2MAPTALDH1A1ADRB3
SCHEMBL6760115 0.91 POLB (0.37) POLBSMN1; SMN2MAPTALDH1A1ADRB3
SCHEMBL14020643 0.89 POLB (0.38) POLBSMN1; SMN2MAPTALDH1A1ADRB3
SCHEMBL313130 0.83 POLB (0.40) POLBSMN1; SMN2MAPTALDH1A1PTPN2
SCHEMBL8253707 0.81 ADRB3 (0.32) ALDH1A1ADRB3ADRA2BADRA2CCTSB
SCHEMBL6823450 0.79 POLB (0.40) POLBSMN1; SMN2MAPTALDH1A1PTPN2
SCHEMBL6828088 0.79 POLB (0.40) POLBSMN1; SMN2MAPTALDH1A1PTPN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2118091-B1 PYRIMIDINE SUBSTITUTED MACROCYCLIC HCV INHIBITORS JANSSEN SCIENCES IRELAND UC (IE) 2015-04-15 — — EP disclosed
Send feedback